Jiwei Ding

519 total citations
35 papers, 374 citations indexed

About

Jiwei Ding is a scholar working on Infectious Diseases, Virology and Molecular Biology. According to data from OpenAlex, Jiwei Ding has authored 35 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 15 papers in Virology and 12 papers in Molecular Biology. Recurrent topics in Jiwei Ding's work include HIV Research and Treatment (15 papers), HIV/AIDS drug development and treatment (11 papers) and interferon and immune responses (4 papers). Jiwei Ding is often cited by papers focused on HIV Research and Treatment (15 papers), HIV/AIDS drug development and treatment (11 papers) and interferon and immune responses (4 papers). Jiwei Ding collaborates with scholars based in China, Canada and Portugal. Jiwei Ding's co-authors include Shan Cen, Jinming Zhou, Xiaoyu Li, Fei Guo, Jianyuan Zhao, Yongxin Zhang, Zeyun Mi, Jian‐Yuan Zhao, Dongrong Yi and Quanjie Li and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and Journal of Virology.

In The Last Decade

Jiwei Ding

32 papers receiving 372 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiwei Ding China 12 151 104 96 86 57 35 374
A Morán Ireland 5 82 0.5× 76 0.7× 50 0.5× 134 1.6× 21 0.4× 11 388
Marni E. Cueno Japan 14 218 1.4× 90 0.9× 25 0.3× 71 0.8× 25 0.4× 44 582
Jiaojiao Hui China 4 216 1.4× 88 0.8× 48 0.5× 261 3.0× 21 0.4× 8 569
Lingjie Zheng China 16 117 0.8× 45 0.4× 54 0.6× 197 2.3× 27 0.5× 31 604
Paula Monteiro Perin Germany 7 94 0.6× 276 2.7× 33 0.3× 98 1.1× 20 0.4× 7 598
Yilei Yang China 12 157 1.0× 92 0.9× 13 0.1× 56 0.7× 49 0.9× 35 423
Meng-Chen Wu Taiwan 13 107 0.7× 71 0.7× 53 0.6× 69 0.8× 43 0.8× 28 397
Aashish Srivastava Norway 14 298 2.0× 56 0.5× 17 0.2× 40 0.5× 160 2.8× 29 497
Jayalakshmi Pailoor Malaysia 15 128 0.8× 42 0.4× 35 0.4× 19 0.2× 42 0.7× 42 493

Countries citing papers authored by Jiwei Ding

Since Specialization
Citations

This map shows the geographic impact of Jiwei Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiwei Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiwei Ding more than expected).

Fields of papers citing papers by Jiwei Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiwei Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiwei Ding. The network helps show where Jiwei Ding may publish in the future.

Co-authorship network of co-authors of Jiwei Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Jiwei Ding. A scholar is included among the top collaborators of Jiwei Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiwei Ding. Jiwei Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Shumin, Ling Ma, Zhen Wang, et al.. (2025). SLFN14 functions as a P-TEFb inhibitor to modulate the transcription of HIV-1 and cellular genes. Science Advances. 11(51). eadt7982–eadt7982.
2.
Ding, Jiwei, et al.. (2025). A new apple polysaccharide for stabilizing goat milk casein dispersion: Rheology, SAXS and intermolecular interaction studies. International Journal of Biological Macromolecules. 318(Pt 3). 145228–145228. 2 indexed citations
5.
Ding, Jiwei, et al.. (2023). Triptolide reduces PD-L1 through the EGFR and IFN-γ/IRF1 dual signaling pathways. International Immunopharmacology. 118. 109993–109993. 13 indexed citations
6.
Li, Yali, Ting Shi, Jian‐Yuan Zhao, et al.. (2023). Teicoplanin derivatives block spike protein mediated viral entry as pan-SARS-CoV-2 inhibitors. Biomedicine & Pharmacotherapy. 158. 114213–114213. 4 indexed citations
7.
Liu, Qian, Dongrong Yi, Jiwei Ding, et al.. (2023). MOV10 recruits DCP2 to decap human LINE ‐1 RNA by forming large cytoplasmic granules with phase separation properties. EMBO Reports. 24(9). e56512–e56512. 7 indexed citations
8.
Zhou, Huiyu, Ling Ma, Biao Dong, et al.. (2022). Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C. European Journal of Medicinal Chemistry. 233. 114251–114251. 6 indexed citations
9.
Zhang, Zixiong, Ning Zhang, Qian Liu, et al.. (2022). The Zinc-Finger protein ZCCHC3 inhibits LINE-1 retrotransposition. Frontiers in Microbiology. 13. 891852–891852. 1 indexed citations
10.
Guo, Saisai, Xiaobo Lei, Yan Chang, et al.. (2022). SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis. Signal Transduction and Targeted Therapy. 7(1). 400–400. 11 indexed citations
11.
Wang, Shujie, Ning Zhang, Zixiong Zhang, et al.. (2022). A High Throughput Cell-Based Screen Assay for LINE-1 ORF1p Expression Inhibitors Using the In-Cell Western Technique. Frontiers in Pharmacology. 13. 881938–881938. 1 indexed citations
12.
Ding, Jiwei, Meng Wu, Chen‐Chao Huang, et al.. (2019). Screening of kinase inhibitors downregulating PD-L1 expression via on/in cell quantitative immunoblots.. European Journal of Pharmaceutical Sciences. 142. 105088–105088. 10 indexed citations
13.
Wang, Jing, Yongxin Zhang, Quanjie Li, et al.. (2019). Influenza Virus Exploits an Interferon-Independent lncRNA to Preserve Viral RNA Synthesis through Stabilizing Viral RNA Polymerase PB1. Cell Reports. 27(11). 3295–3304.e4. 56 indexed citations
14.
Ding, Jiwei, Jianyuan Zhao, Jinming Zhou, et al.. (2018). Association of gene polymorphism of SDF1(CXCR12) with susceptibility to HIV-1 infection and AIDS disease progression: A meta-analysis. PLoS ONE. 13(2). e0191930–e0191930. 6 indexed citations
15.
Ma, Ling, Zhixin Zhang, Jiwei Ding, et al.. (2017). Identification and characterization of loop7 motif and its role in regulating biological function of human APOBEC3G through molecular modeling and biological assay. Acta Pharmaceutica Sinica B. 7(5). 571–582. 5 indexed citations
16.
Zhang, Quan, Zeyun Mi, Yuming Huang, et al.. (2016). 2-thio-6-azauridine inhibits Vpu mediated BST-2 degradation. Retrovirology. 13(1). 13–13. 12 indexed citations
17.
Ding, Jiwei, et al.. (2016). [The sensitivity of transmitted/founder HIV-1 to anti-HIV drugs].. PubMed. 51(3). 367–72. 1 indexed citations
18.
Ding, Jiwei, et al.. (2016). Citron kinase enhances ubiquitination of HIV-1 Gag protein and intracellular HIV-1 budding. Archives of Virology. 161(9). 2441–2448. 12 indexed citations
19.
Mi, Zeyun, Jiwei Ding, Quan Zhang, et al.. (2015). A small molecule compound IMB-LA inhibits HIV-1 infection by preventing viral Vpu from antagonizing the host restriction factor BST-2. Scientific Reports. 5(1). 18499–18499. 17 indexed citations
20.
Shang, Hongtao, et al.. (2015). Progress and challenges in the use of latent HIV-1 reactivating agents. Acta Pharmacologica Sinica. 36(8). 908–916. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026